Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Early detection of Alzheimer's disease with PET imaging.

Literature DB >> 20197691

Early detection of Alzheimer's disease with PET imaging.

V Berti¹, R S Osorio, L Mosconi, Y Li, S De Santi, M J de Leon.

Abstract

Preclinical diagnosis of Alzheimer's disease (AD) is one of the major challenges for the prevention of AD. AD biomarkers are needed not only to reveal preclinical pathologic changes, but also to monitor progression and therapeutics. PET neuroimaging can reliably assess aspects of the molecular biology and neuropathology of AD. The aim of this article is to review the use of FDG-PET and amyloid PET imaging in the early detection of AD. Copyright 2010 S. Karger AG, Basel.

Entities: Chemical Disease

Mesh：

Substances：
Fluorodeoxyglucose F18

Year: 2010 PMID： 20197691 PMCID： PMC3214828 DOI： 10.1159/000289222

Source DB: PubMed Journal: Neurodegener Dis ISSN： 1660-2854 Impact factor: 2.977

32 in total

1. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

Authors: M J de Leon; A Convit; O T Wolf; C Y Tarshish; S DeSanti; H Rusinek; W Tsui; E Kandil; A J Scherer; A Roche; A Imossi; E Thorn; M Bobinski; C Caraos; P Lesbre; D Schlyer; J Poirier; B Reisberg; J Fowler
Journal: Proc Natl Acad Sci U S A Date: 2001-08-28 Impact factor: 11.205

2. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors: S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal: Neurology Date: 1991-04 Impact factor: 9.910

3. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.

Authors: Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal: Proc Natl Acad Sci U S A Date: 2003-12-19 Impact factor: 11.205

4. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging.

Authors: Henry Rusinek; Susan De Santi; Dina Frid; Wai-Hon Tsui; Chaim Y Tarshish; Antonio Convit; Mony J de Leon
Journal: Radiology Date: 2003-12 Impact factor: 11.105

Review 5. Toward a molecular neuropsychiatry of neurodegenerative diseases.

Authors: Jeffrey L Cummings
Journal: Ann Neurol Date: 2003-08 Impact factor: 10.422

6. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Authors: Alexander Drzezga; Nicola Lautenschlager; Hartwig Siebner; Matthias Riemenschneider; Frode Willoch; Satoshi Minoshima; Markus Schwaiger; Alexander Kurz
Journal: Eur J Nucl Med Mol Imaging Date: 2003-05-23 Impact factor: 9.236

7. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors: William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422

8. Amyloid imaging in mild cognitive impairment subtypes.

Authors: David A Wolk; Julie C Price; Judy A Saxton; Beth E Snitz; Jeffrey A James; Oscar L Lopez; Howard J Aizenstein; Ann D Cohen; Lisa A Weissfeld; Chester A Mathis; William E Klunk; Steven T De-Kosky; Steven T DeKoskym
Journal: Ann Neurol Date: 2009-05 Impact factor: 10.422

9. Cortical abnormalities in Alzheimer's disease.

Authors: N L Foster; T N Chase; L Mansi; R Brooks; P Fedio; N J Patronas; G Di Chiro
Journal: Ann Neurol Date: 1984-12 Impact factor: 10.422

10. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons.

Authors: Anne B Rocher; Françoise Chapon; Xavier Blaizot; Jean-Claude Baron; Chantal Chavoix
Journal: Neuroimage Date: 2003-11 Impact factor: 6.556

23 in total

Review 1. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors: Sergio T Ferreira; William L Klein
Journal: Neurobiol Learn Mem Date: 2011-09-06 Impact factor: 2.877

Review 2. Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors: Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal: Chem Soc Rev Date: 2011-05-23 Impact factor: 54.564

3. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

Authors: Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Annapaola Prestia; Anna Caroli; Isabella Castiglioni; Maria Carla Gilardi; Giovanni Frisoni; Karl Friston; John Ashburner; Daniela Perani
Journal: Neuroinformatics Date: 2014-10

4. Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease.

Authors: Yajing Liu; Lin Zhu; Karl Plössl; Seok Rye Choi; Hongwen Qiao; Xiaotao Sun; Song Li; Zhihao Zha; Hank F Kung
Journal: Nucl Med Biol Date: 2010-06-29 Impact factor: 2.408

5. Neurological imaging: statistics behind the pictures.

Authors: Ivo D Dinov
Journal: Imaging Med Date: 2011-08-01

6. Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosis.

Authors: James E Galvin
Journal: Prion Date: 2011-01-01 Impact factor: 3.931

Review 7. Early diagnosis of disease using microbead array technology: A review.

Authors: Sanam Foroutan Parsa; Atieh Vafajoo; Azin Rostami; Reza Salarian; Mohammad Rabiee; Navid Rabiee; Ghazal Rabiee; Mohammadreza Tahriri; Amir Yadegari; Daryoosh Vashaee; Lobat Tayebi; Michael R Hamblin
Journal: Anal Chim Acta Date: 2018-05-04 Impact factor: 6.558